Beyond cancer, MIF has been linked to IL-17 expression in various autoimmune disorders, such as Hashimoto’s thyroiditis and rheumatoid arthritis, where Th17-mediated responses are known to drive pro-inflammatory processes (95, 96). Here, MIF is linked to cancer.